CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Amneal Pharmaceuticals, LLC recalls Ropivacaine Hydrochloride Injection

Read the official FDA notice

Published
14 May 2025
Units affected
62 (12x100mL) bags
Agency
FDA
Country
United States

The hazard

Presence of Particulate Matter

Classification: Class I — the most serious type: there is a reasonable chance this product could cause serious health problems or death.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Ropivacaine Hydrochloride Injection, USP, 0.5%, 500 mg per 100 mL (5mg/mL), Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Mehsana, India, , Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807 NDC 70121-1734-1 (bag); NDC 70121-1734-3 (box)

Brand / company
Amneal Pharmaceuticals, LLC
Codes / lots
Lot #'s: AL240003, AL240004, Exp.: 01/31/2026
Distribution
Nationwide in the US
Recall status
Terminated

Source: U.S. Food and Drug Administration, published 14 May 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.